July 13, 2021Schizophrenia BulletinOpen Access

Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data

View Full Paper

Ask AI

Bookmark

Abstract

Our results corroborate the high relapse risk following antipsychotic withdrawal after symptom stabilization with limited patient-related predictors of safe treatment discontinuation. Stabilization with LAIs reduces the short-/medium-term relapse risk.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schoretsanitis et al. (2021) studied this question.

synapsesocial.com/papers/69d76277f07a12db70b8acaf https://doi.org/10.1093/schbul/sbab091

View Full Paper

Ask AI

Bookmark

Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data

Abstract

Discussion

Cite This Study

Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data

Abstract

Discussion

Cite This Study

Keep reading

Keep reading